Exact Sciences highlights CMS advisory panel’s unanimous vote to maintain Medicare reimbursement rate for Cologuard®
MADISON, Wis.–(BUSINESS WIRE)– Exact Sciences Corp. (NASDAQ: EXAS) today announced that the Centers for Medicare and Medicaid Services (CMS) Advisory Panel on Clinical Diagnostic Laboratory Tests voted unanimously to...
Read More